User profiles for Caroline S. Copeland

Caroline Copeland

Senior Lecturer in Pharmacology & Toxicology, King's College London
Verified email at kcl.ac.uk
Cited by 708

Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors

…, L Lionetto, M Curto, L Iacovelli, CS Copeland… - …, 2017 - Elsevier
Cinnabarinic and xanthurenic acids are kynurenine metabolites generated by oxidative
dimerization of 3-hydroxyanthranilic acid and transamination of 3-hydroxykynurenine, …

Fatalities associated with gabapentinoids in England (2004–2020)

…, BD Williams, D Taylor, CS Copeland - British journal of …, 2022 - Wiley Online Library
… The authors confirm that the Principal Investigator for this paper is Caroline S. Copeland.
She had direct responsibility for the data (note: patient consent was not applicable to this study …

[PDF][PDF] Robotic automation of in vivo two-photon targeted whole-cell patch-clamp electrophysiology

LA Annecchino, AR Morris, CS Copeland, OE Agabi… - Neuron, 2017 - cell.com
Whole-cell patch-clamp electrophysiological recording is a powerful technique for studying
cellular function. While in vivo patch-clamp recording has recently benefited from automation, …

Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019

…, H Claridge, C Goodair, CS Copeland… - Journal of …, 2021 - journals.sagepub.com
Background: Ketamine is a phencyclidine derivative with dissociative anaesthetic properties.
Increasing numbers of individuals in England take ketamine recreationally. Information on …

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)

…, B McClure, AH Young, CS Copeland… - Journal of …, 2022 - journals.sagepub.com
Background: Recreational lysergic acid diethylamide (LSD) use is growing in popularity amid
increasing research interest on psychedelics and their possible therapeutic potential yet; …

[HTML][HTML] The first drug-related death associated with xylazine use in the UK and Europe

…, J Duffy, A Mellor, R Treble, CS Copeland - Journal of forensic and …, 2023 - Elsevier
Background and aims On November 8th , 2022, the United States Food and Drug
Administration (FDA) issued a statement alerting healthcare professionals to the increasing …

[HTML][HTML] Trends in deaths following drug use in England before, during, and after the COVID-19 lockdowns

…, BD Williams, NJ Kalk, CS Copeland - Frontiers in public …, 2023 - frontiersin.org
Aim This research aimed to describe how the characteristics of deaths following drug use
changed during the COVID-19 pandemic in England, and how this can inform future strategy to …

Advances in two-photon scanning and scanless microscopy technologies for functional neural circuit imaging

SR Schultz, CS Copeland, AJ Foust… - Proceedings of the …, 2016 - ieeexplore.ieee.org
Recent years have seen substantial developments in technology for imaging neural circuits,
raising the prospect of large-scale imaging studies of neural populations involved in …

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016

…, HJ Hamnett, CS Copeland - Journal of …, 2021 - journals.sagepub.com
Background: ‘Legal highs’ began appearing in the UK in the mid-2000s. Whilst many of these
substances were controlled under the 1971 Misuse of Drugs Act, novel compounds and …

Synthetic cannabinoid-related deaths in England, 2012–2019

…, A Englund, NJ Kalk, CS Copeland - Cannabis and …, 2022 - liebertpub.com
Aim: To identify drug-related death trends associated with synthetic cannabinoid receptor
agonists (SCRAs) reported to the National Programme on Substance Abuse Deaths (NPSAD) …